Amro Tablets SpecificationRequires Prescription (YES/NO)YesGenericsRosuvastatinUsed ForCholesterol ControlHow it worksThe primary site of action of rosuvastatin is the liver, the target organ for cholesterol lowering. Rosuvastatin increases the number of hepatic LDL receptors on the cell-surface, enhancing uptake and catabolism of LDL and it inhibits the hepatic synthesis of VLDL, thereby reducing the total number of VLDL and LDL particles.Amro Tablets Usage And SafetyDosageRosuvastatinSide EffectsHeadache, dizziness, constipation, nausea, abdominal pain, myalgia, asthenia, diabetic mellitus Pruritus, rash and urticaria , Hypersensitivity reactions including angioedema, myopathy, rhabdomyolysis, pancreatitis.Drug InteractionsCoumarin anticoagulants , Gemfibrozil , antacid suspension containing aluminium and magnesium hydroxide , Niacin.IndicationRosuvastatin is indicated for the treatment of: Hyperlipidemia and Mixed Dyslipidemia As adjunctive therapy to diet to reduce elevated Total-C, LDL-C, ApoB, nonHDL-C, and triglycerides and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia.When not to UseRosuvastatin is contraindicated:- In patients with hypersensitivity to rosuvastatin or to any of the excipients.- In patients with active liver disease including unexplained, persistent elevations of serum transaminases and any serum transaminases elevation exceeding 3x the upper limit of normal (ULN).Amro Tablets PrecautionsPrecautionWhen initiating (Rosuvastatin) therapy or switching from another HMG-CoA reductase inhibitor therapy, the appropriate (Rosuvastatin) starting dose should first be utiized, and only then titrated according to the patient's response and individualized goal of therapy.Amro Tablets WarningsWarning 1Rosuvastatin should be used with caution in patients who consume substantial quantities of alcohol and/or have a history of chronic liver disease.Warning 2A dose reduction should be considered for patients on rosuvastatin therapy with unexplained persistent proteinuria and/or hematuria during routine urinalysis testing.Warning 3Rosuvastatin should be prescribed with caution in patients with predisposing factors for myopathy/rhabdomyolysis. . Such factors include: renal insufficiency, hypothyroidism, personal or family history ofhereditary muscular disorders, previous history of muscular toxicity with another HMG-CoA reductase inhibitor or fibrate, alcohol abuse.Amro Tablets Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store this medicine at room temperature, away from direct light and heat.
ARBAZEAL ES 40 MG TAB 10`S ₦2,240.75
ETORNEXT ER 600MG TABLET ₦4,477.75
DIAPRIDE M 1MG FORTE STRIP OF 15 TABLETS ₦2,578.25
Amro Tablets SpecificationRequires Prescription (YES/NO)YesGenericsRosuvastatinUsed ForCholesterol ControlHow it worksThe primary site of action of rosuvastatin is the liver, the target organ for cholesterol lowering. Rosuvastatin increases the number of hepatic LDL receptors on the cell-surface, enhancing uptake and catabolism of LDL and it inhibits the hepatic synthesis of VLDL, thereby reducing the total number of VLDL and LDL particles.Amro Tablets Usage And SafetyDosageRosuvastatinSide EffectsHeadache, dizziness, constipation, nausea, abdominal pain, myalgia, asthenia, diabetic mellitus Pruritus, rash and urticaria , Hypersensitivity reactions including angioedema, myopathy, rhabdomyolysis, pancreatitis.Drug InteractionsCoumarin anticoagulants , Gemfibrozil , antacid suspension containing aluminium and magnesium hydroxide , Niacin.IndicationRosuvastatin is indicated for the treatment of: Hyperlipidemia and Mixed Dyslipidemia As adjunctive therapy to diet to reduce elevated Total-C, LDL-C, ApoB, nonHDL-C, and triglycerides and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia.When not to UseRosuvastatin is contraindicated:- In patients with hypersensitivity to rosuvastatin or to any of the excipients.- In patients with active liver disease including unexplained, persistent elevations of serum transaminases and any serum transaminases elevation exceeding 3x the upper limit of normal (ULN).Amro Tablets PrecautionsPrecautionWhen initiating (Rosuvastatin) therapy or switching from another HMG-CoA reductase inhibitor therapy, the appropriate (Rosuvastatin) starting dose should first be utiized, and only then titrated according to the patient's response and individualized goal of therapy.Amro Tablets WarningsWarning 1Rosuvastatin should be used with caution in patients who consume substantial quantities of alcohol and/or have a history of chronic liver disease.Warning 2A dose reduction should be considered for patients on rosuvastatin therapy with unexplained persistent proteinuria and/or hematuria during routine urinalysis testing.Warning 3Rosuvastatin should be prescribed with caution in patients with predisposing factors for myopathy/rhabdomyolysis. . Such factors include: renal insufficiency, hypothyroidism, personal or family history ofhereditary muscular disorders, previous history of muscular toxicity with another HMG-CoA reductase inhibitor or fibrate, alcohol abuse.Amro Tablets Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store this medicine at room temperature, away from direct light and heat.
Amorolfine 0.25 %W/W
Amorolfine 0.25 %W/W
Description Contributes in Safe & Effective Gastro Care Provides comprehensive management in 1st & 2nd degree Haemorrhoids A supportive therapy in 3rd & 4th degree Hemorrhoids An adjunct therapy for pre & post operative Hemorrhoids management Regulates bowel movement Helps prevent recurrence in post operative Hemorrhoids cases Ingredients Each cellulose capsule of approx. 560 mg contains: A. Dried aqueous extracts derived from : An equi. Mix of Emblica officinalis + Terminalia chebula + Terminalia bellirica 400 mg, Amorphophallus campanulatus 400 mg, Mesua ferrea 300 mg, Cynodon dactylon 300 mg, Terminalia chebula 300 mg, Callicarpa macrophylla 200 mg, Emblica officinalis 200 mg, Foeniculum vulgare 100 mg, Picrorhiza kurroa 100 mg, Holoptelea integrifolia 100 mg, Curcuma longa 100 mg, Symplocos racemosa 50 mg, Zingiber officinale 50 mg, Blumea lacera 50 mg, Pongamia pinnata 50 mg, Aloe vera 50 mg, B. Powders : Bombax malabaricum 20 mg, Shorea robusta 20 mg, Piper longum 20 mg, Commiphora myrrha 20 mg, Cocos nucifera 20 mg, Berberis aristata 20 mg, Sterculia urens 20 mg, Daemonorops draco 15 mg, Excipients Q.S. Preservative ? Sodium Benzoate
Description Contributes in Safe & Effective Gastro Care Provides comprehensive management in 1st & 2nd degree Haemorrhoids A supportive therapy in 3rd & 4th degree Hemorrhoids An adjunct therapy for pre & post operative Hemorrhoids management Regulates bowel movement Helps prevent recurrence in post operative Hemorrhoids cases Ingredients Each gm. of ointment contains : A. Aqueous extract derived from : An equi mix of T. chebula + E. officinalis + T. belerica 30 mg, Mesua ferrea 20 mg, Vitex negundo 20 mg, Tagetes erecta 20 mg, Aloe vera 20 mg, Butea monosperma 20 mg, Mimosa pudica 20 mg, Curcuma longa 20 mg, Amorphophalus campanulatus 20 mg, Cynodon dactylon 20 mg, Holoptelea integrifolia 20 mg, Piper betle 10 mg, B. Powders : Berberis aristata 50 mg, Purified Borax 50 mg, Yashad bhasam (Classical Ay. Preparation Prcd.) 50 mg, Shorea robusta 20 mg, Cocos nucifera 10 mg, Panchkshar (Classical Ay. Preparation, Prcd.) 10 mg, Commiphora myrrha 5 mg, Cinnamomum camphora (champhor) 5 mg, Mentha sps. (menthol) 3 mg, Sphatic bhasam (Classical Ay. Preparation, Prcd.) 3 mg, Tuttha sudh (Classical Ay. Preparation Prcd.) 0.1 mg, C. Oils : Kasisadya taila (Classical Ay. Preparation Prcd.) 30 mg, Jatyadi taila (Classical Ay. Preparation, Prcd.) 25 mg, Azadirachta indica Oil 0.1 ml, Jasminum officinale Oil Q.S., D. Liquid: Euphorbia nerifolia 0.01 ml., Ointment Base Q.S., Excipients Q.S., Preservatives ? Methylparaben & Propylparabe Benefits Provides comprehensive management in 1st & 2nd degree Haemorrhoids A supportive therapy in 3rd & 4th degree Hemorrhoids An adjunct therapy for pre & post operative Hemorrhoids management Regulates bowel movement Helps prevent recurrence in post operative Hemorrhoids cases
Amorolfine 0.25 %W/W
Amorolfine 0.25 %W/W
Amorolfine 0.25 %W/W
Amorolfine 0.25 %W/W
Amrolstar Cream, 30gm
Amrolstar Cream, 50gm
Amrolstar Lotion (30ml)
Amrolstar Lotion, 30ml Pack of 2